| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.3B | $10.5B | $9.5B | $10.5B | $9.0B | $7.5B | $7.4B | $7.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.3B | $1.7B | $1.6B | $1.7B | $1.2B | $0.3B | $0.3B | $0.2B |
| EPS (Basic) | $462.00 | $540.88 | $491.52 | $525.20 | $345.37 | $244.11 | $241.31 | $219.58 |
| EPS (Diluted) | $436.55 | $506.69 | $463.31 | $491.82 | $320.48 | $76.93 | $64.41 | $58.57 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.9B | $6.4B | $6.6B | $5.7B | $5.8B | $5.8B | $3.8B | $3.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | $2.8B | — | $0.7B |
| Total Liabilities | $2.0B | $2.2B | $2.2B | $2.2B | $2.8B | $2.7B | $1.5B | $1.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.9B | $4.2B | $4.4B | $3.5B | $3.0B | $3.1B | $2.3B | $1.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.4B | $1.5B | $1.9B | $1.2B | $0.9B | $0.9B | — |
| Investing Cash Flow | $-0.1B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | — |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-1.8B | $-1.9B | $-0.8B | $-1.9B | $-1.4B | $0.7B | $-0.4B | — |